Arnold Schwartz

Dr. Arnold Schwartz


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
Aileen ChangAileen Chang
Aileen Chang
STSarah R. Tritsch
Sarah R. Tritsch
APAbigail J. Porzucek
Abigail J. Porzucek
ASArnold Schwartz
Arnold Schwartz
MSMargaux Seyler-Schmidt
Margaux Seyler-Schmidt
CMChristopher N. Mores
Christopher N. Mores
Chikungunya virus (CHIKV) was introduced to the Americas in 2013, causing two million infections across over thirty countries. CHIKV causes a chronic debilitating arthritis in one fourth of infected individuals and currently evidence-based targeted therapies for the treatment of CHIKV arthritis are lacking. Multiple mouse models of chikungunya have been developed to study acute CHIKV infection. In humans, post-CHIKV arthritis may persist for months to years after viremia from a CHIKV infection has resolved. Therefore, the development of a mouse model of post-acute arthritis of chikungunya may facilitate the study of potential novel therapeutics for this arthritis. In this article we describe the development of a wild-type immunocompetent C57BL/6 mouse model for post-acute arthritis of chikungunya, including a histologic inflammation scoring system, as well as suggestions for how this mouse model may be used to examine the efficacy of novel therapies for CHIKV arthritis.

1 September 2015 in Chest
Verified
Journal Article
Closed access
PDF file
ASArnold Schwartz
Arnold Schwartz
DHDonald E. Henson
Donald E. Henson